Clinical trial
A Randomized Controlled Trial of VSL#3 for the Prevention of Endoscopic…
NCT00175292 · University of Alberta, Other · Completed
Key facts
| NCT number | NCT00175292 |
|---|---|
| Title | A Randomized Controlled Trial of VSL#3 for the Prevention of Endoscopic Recurrence Following Surgery for Crohn's Disease. |
| Official title | A Randomized and Placebo-Controlled Double-Blind Multicentre Study to Determine the Efficacy and Safety of VSL#3 Probiotic Food Supplement Mixture in Prevention of Endoscopic Recurrence in Crohn's Disease Patients With Ileocolonic Surgical Resection and Small Intestine to Colon Anastomosis. |
| Lead sponsor | University of Alberta, Other |
| Collaborators | Canadian Institutes of Health Research (CIHR) |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Crohn's Disease, Inflammatory Bowel Disease |
| Intervention type | Drug |
| Interventions | Probiotic - VSL#3 |
| Enrollment | 120 |
| Start date | Dec 1, 2003 |
| First posted | Sep 15, 2005 |
| Last update posted | May 14, 2008 |
| Countries | Canada |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: